Bilateral Testicular Germ Cell Tumors: A Case-Series From a UK-Based Tertiary Referral Center Over 19 Years

被引:6
作者
Watson, Robert A. [1 ]
Morgan, Robert D. [1 ]
Joseph, Johnson [1 ]
Sivakumar, Shivan [1 ]
Verrill, Clare [2 ]
Tuthill, Mark [1 ]
Sullivan, Mark [3 ]
Protheroe, Andrew S. [1 ]
机构
[1] Churchill Hosp, Oxford Canc Ctr, Dept Med Oncol, Oxford OX3 7LE, England
[2] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England
[3] Oxford Univ Hosp, Dept Urol, Oxford, England
关键词
Bilateral testicular cancer; Metachronous tumours; Nonseminomatous germ cell tumor; Seminoma; Synchronous tumours; CENTER EXPERIENCE; CANCER-CENTER; RISK; MANAGEMENT;
D O I
10.1016/j.clgc.2018.02.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bilateral testicular germ cell tumors (TGCTs) are a rare occurrence, with a frequency in this series of 1.4% of all testicular cancer cases. However, patients with a diagnosis of TGCT have a vastly increased risk of developing a second tumor compared with the a priori risk for a healthy individual to develop TGCT. Because of the low incidence, most knowledge and understanding of this disease comes from case series and reports; to our knowledge this is the largest series published from a United Kingdom center in recent years. Most bilateral TGCT are metachronous, with a small percentage (33%) synchronous. The first tumor can present at a wide range of ages (19-75 years), with median age of first presentation 29 years. For metachronous tumors, the median time to second tumor presentation was 6.1 years, indicating that longer follow-up might be indicated for detecting a second tumor. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:E513 / E516
页数:4
相关论文
共 19 条
[1]  
[Anonymous], POP EST UK ENGL WAL
[2]  
[Anonymous], TEST CANC INC STAT
[3]   TREATMENT OF TESTICULAR CANCER AND THE DEVELOPMENT OF SECONDARY MALIGNANCIES [J].
BOKEMEYER, C ;
SCHMOLL, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :283-292
[4]   Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality [J].
Bray, Freddie ;
Richiardi, Lorenzo ;
Ekbom, Anders ;
Pukkala, Eero ;
Cuninkova, Martina ;
Moller, Henrik .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (12) :3099-3111
[5]  
Campobasso D, 2017, WSPOLCZESNA ONKOL, V21, P70, DOI 10.5114/wo.2017.66660
[6]  
Coogan CL, 1998, CANCER, V83, P547, DOI 10.1002/(SICI)1097-0142(19980801)83:3<547::AID-CNCR24>3.0.CO
[7]  
2-V
[8]   Risk of contralateral testicular cancer:: A population-based study of 29515 US men [J].
Fosså, SD ;
Chen, JB ;
Schonfeld, SJ ;
McGlynn, KA ;
McMaster, ML ;
Gail, MH ;
Travis, LB .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (14) :1056-1066
[9]  
Geczi L, INCIDENCE PROGNOSIS
[10]   Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: The Memorial Sloan Kettering Cancer Center experience 1950 to 2001 [J].
Holzbeierlein, JM ;
Sogani, PC ;
Sheinfeld, J .
JOURNAL OF UROLOGY, 2003, 169 (06) :2122-2125